Noida, UP -- (SBWire) -- 06/30/2015 --According to a new research report by RNCOS entitled, "US Proton Therapy Market Outlook 2020", US dominates the proton therapy market in the world and the other developed countries such as Canada, UK and Australia are expected to capture a significant share in the Global Proton Therapy Market. Procure is considered to be the largest service provider in the proton therapy market and it accounts for about 22% of the total US Proton Therapy Market.
The market, which stood at US$ 640 Million in 2014, has potential to report a significant growth in the next six years. The market is anticipated to grow at 11.4% CAGR to become US$ 1.22 Billion. Among the various types of cancer, Breast cancer has been the fastest growing cancer by site. IBA Group, Varian Medical, Hitachi and Mevion Medical Systems are top four proton therapy equipment providers.
Research Analysis & Highlights
The report is spread in over 70 pages and provides an in-depth research and rational analysis of the current status and future prospect of the US Proton Therapy Industry. The study presents a transparent picture about different cancer incidence facts such as the number of cancer deaths by state and site. Each proton therapy center in the country has been evaluated sincerely, to estimate the shortage of number of centers in the each state. The research further covers current radiation therapies available in the market, detailed analysis of potential cancer patients by each state (2014 & 2020), Growth Drivers and Challenges as well as the industry trends.
The report also covers detailed information about active market players in the US proton therapy industry, including domestic and foreign players to enable the clients to understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the US Proton Therapy industry, providing an in-depth research and prudent analysis of the key segments.
Some of the key highlights of the report include:
- Growth Drivers such as increasing government support, Benefits over conventional radiation therapies and increasing incidence of cancer
- Detailed analysis of potential cancer patients by state in 2014 & 2020
- Analysis of existing and forthcoming players, service and equipment providers
- Leading Players and their share in US Proton Therapy market
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM763.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
US Proton Therapy Industry to Witness Astounding Growth in Six Years
“Increasing incidence of cancer, benefits over conventional radiation therapies and increased government participation will drive the US proton therapy market to become US$ 1.2 Billion by 2020”, says RNCOS.